Asarina Pharma AB (STU:APS) FCF Yield % : -61.24 (As of Jun. 08, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Asarina Pharma AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Asarina Pharma AB's Trailing 12-Month Free Cash Flow is €-1.01 Mil, and Market Cap is €1.63 Mil. Therefore, Asarina Pharma AB's FCF Yield % for today is -61.24%.

The historical rank and industry rank for Asarina Pharma AB's FCF Yield % or its related term are showing as below:

STU:APS' s FCF Yield % Range Over the Past 10 Years
Min: -66.59 Med: 0 Max: 0
Current: -61.24

STU:APS's FCF Yield % is ranked worse than
78.19% of 1554 companies
in the Biotechnology industry
Industry Median: -13.915 vs STU:APS: -61.24

Asarina Pharma AB's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Asarina Pharma AB FCF Yield % Historical Data

The historical data trend for Asarina Pharma AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB FCF Yield % Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-69.29

-119.33

-49.87

-63.78

Asarina Pharma AB Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-73.65	-75.47	-	-	-

Competitive Comparison of Asarina Pharma AB's FCF Yield %

For the Biotechnology subindustry, Asarina Pharma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asarina Pharma AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asarina Pharma AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Asarina Pharma AB's FCF Yield % falls into.

Asarina Pharma AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Asarina Pharma AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.008	/	1.58036972
	=	-63.78%

Asarina Pharma AB's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	1.58036972
	=	0.00%

Asarina Pharma AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Asarina Pharma AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB (STU:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (STU:APS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ASAP:Sweden

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (STU:APS) Headlines

No Headlines